Security record · archived quarter
ABSI
Absci Corporation · Healthcare · Biotechnology
9Tracked holders
0Δ holders
11.86MShares held
$45.29MReported value
+1New positions
−1Exits
Momentum inputs (comparable managers): holder breadth 0.0% · share flow -2.4% · net new positions 0.0% · formula
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2024
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 36.37K | $325,139 | n/a | n/a |
| Q2 2026 | 82 | +7 | 112.04M | $1.30B | +11 | −4 |
| Q1 2026 | 77 | +13 | 90.86M | $272.61M | +16 | −3 |
| Q4 2025 | 64 | 0 | 89.20M | $311.30M | n/a | n/a |
| Q3 2025 | 15 | -1 | 60.11M | $182.75M | +1 | −2 |
| Q2 2025 | 13 | 0 | 50.18M | $128.95M | +2 | −2 |
| Q1 2025 | 10 | 0 | 17.56M | $44.09M | +1 | −1 |
| Q4 2024 | 10 | 0 | 15.09M | $39.55M | +1 | −1 |
| Q3 2024 | 9 | 0 | 11.86M | $45.29M | +1 | −1 |
| Q2 2024 | 9 | n/a | 12.14M | $37.33M | n/a | n/a |
Who holds it · Q3 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | ARK Investment Management ✦ | 6.34M | +15.2% | $24.21M | 0.2% | ▲ Add | 2 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 1.93M | +6.8% | $7.39M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 3 | Marshall Wace ✦ | 1.30M | -28.9% | $4.98M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | Millennium Management ✦ | 1.17M | +44.7% | $4.49M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 5 | Two Sigma Investments ✦ | 456.24K | -38.2% | $1.74M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | Wellington Management ✦ | 348.85K | +44.8% | $1.33M | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
| 7 | D. E. Shaw & Co. ✦ | 245.77K | -26.4% | $938,841 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | AQR Capital Management ✦ | 28.44K | New | $108,629 | 0.0% | New | 1 | SEC ↗ ×2 |
| 9 | T. Rowe Price ✦ | 25.59K | 0.0% | $98,000 | 0.0% | Held | 2 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| AQR Capital Management | $108,629 | 0.0% |
Exited
| Citadel Advisors | $2.61M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 159 holders, 118.34M shares, $354.64M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q3 2024 ·
Methodology ·
Get this via the API